RP
ATRC icon

Riverwater Partners’s AtriCure ATRC Stock Holding History

Riverwater Partners’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2M Buy
71,596
+1,090
+2% +$30.7K 0.59% 65
2026
Q1 		$2.01M Buy
70,506
+10,184
+17% +$348K 0.67% 55
2025
Q4 		$2.39M Hold
60,322
– – 0.92% 29
2025
Q3 		$2.13M Buy
60,322
+26,657
+79% +$918K 0.88% 30
2025
Q2 		$1.1M Buy
+33,665
New +$1.09M 0.52% 65

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Riverwater Partners's ATRC Position: Q2 2026 in Review

Riverwater Partners increased its AtriCure (ATRC) stake by 1.5% in Q2 2026, buying an estimated $30.7K and bringing the position to 71,596 shares worth $2M. The position accounts for 0.59% of the portfolio, ranked #65.

Riverwater Partners first reported a position in ATRC in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.39M in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Riverwater Partners held 71,596 shares of AtriCure worth $2M as of Q2 2026.
  • Riverwater Partners bought 1,090 AtriCure shares in Q2 2026, an estimated $30.7K.
  • AtriCure made up 0.59% of Riverwater Partners's portfolio in Q2 2026, its #65 holding.
  • Riverwater Partners first reported a position in AtriCure in Q2 2025 and has held it in 5 quarters since.
  • Riverwater Partners's AtriCure position peaked at $2.39M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Riverwater Partners's 13F filing for Q2 2026, filed 14 Aug 2026.